CINDY MORA: Open Payments
NPI 1891385464 · PALM SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 23 payments from 8 companies in 2025. Trend: 2023 $646 · 2024 $624 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $163 |
| Sumitomo Pharma America, Inc. | 6 | $123 |
| Astellas Pharma Global Development | 1 | $105 |
| Exact Sciences Corporation | 2 | $56 |
| Biogen, Inc. | 2 | $51 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $38 |
| Organon LLC | 1 | $20 |
| Exeltis, USA Inc. | 1 | $20 |
Products named: Veozah, MYFEMBREE, The Cologuard Plus Collection Kit, ZURZUVAE, NEXPLANON, SLYND, GEMTESA.
Industry payments across FL — which companies pay providers there.
